Aakaar Medical Technologies Annual Financials | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 13 | 20 | 33 | 46 | 62 | 0 |
Expenses | 12 | 17 | 29 | 41 | 52 | 0 |
EBITDA  | 1 | 2 | 4 | 5 | 10 | 0 |
Operating Profit % | 7 % | 12 % | 11 % | 11 % | 16 % | 0 % |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
Interest | 0 | 0 | 0 | 1 | 2 | 0 |
Profit Before Tax  | 1 | 2 | 3 | 4 | 8 | 0 |
Tax | 0 | 1 | 1 | 1 | 2 | 0 |
Net Profit | 1 | 2 | 2 | 3 | 6 | 0 |
EPS in ₹ | 54.44 | 1.78 | 2.37 | 3.15 | 6.13 | 0.00 |
Above figures are in Rs. Crores Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
Total Assets  | 14 | 18 | 23 | 34 | 54 |
Fixed Assets | 0 | 0 | 0 | 0 | 0 |
Current Assets | 14 | 17 | 22 | 33 | 52 |
Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 |
Other Assets | 14 | 18 | 23 | 34 | 54 |
Total Liabilities  | 14 | 18 | 23 | 34 | 54 |
Current Liabilities | 3 | 10 | 13 | 21 | 30 |
Non Current Liabilities | 4 | 1 | 1 | 1 | 1 |
Total Equity  | 7 | 8 | 10 | 13 | 23 |
Reserve & Surplus | 7 | 7 | 9 | 12 | 13 |
Share Capital | 0 | 1 | 1 | 1 | 10 |
Above figures are in Rs. Crores Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
Net Cash Flow | 3 | -1 | -2 | 0 | 5 |
Investing Activities | 0 | -0 | -0 | 0 | -0 |
Operating Activities | 4 | 1 | -3 | -8 | -5 |
Financing Activities | -2 | -1 | 1 | 8 | 11 |
Above figures are in Rs. Crores % Holding | Feb 2025 | Jun 2025 |
Promoter | 91.12 % | 91.12 % |
FIIs | 0.00 % | 0.00 % |
DIIs | 0.00 % | 0.00 % |
Government | 0.00 % | 0.00 % |
Public / Retail | 0.00 % | 0.00 % |
Others | 8.88 % | 8.88 % |
No of Share Holders | 11 | 11 |
RSI(14)

Overbought
81.13
ATR(14)

Volatile
5.43
STOCH(9,6)

Overbought
90.40
STOCH RSI(14)

Oversold
0.00
MACD(12,26)

Bearish
0.00
ADX(14)

Weak Trend
0.00
UO(9)

Bullish
0.00
ROC(12)

Uptrend And Accelerating
55.80
WillR(14)

Overbought
-8.49